# Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer

> **NCT00064285** · PHASE1 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 22 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** alvocidib
- **DRUG:** imatinib mesylate

## Key facts

- **NCT ID:** NCT00064285
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2010-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00064285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00064285, "Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00064285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*